These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24326357)

  • 1. [Oncological imaging for therapy response assessment].
    Stattaus J
    Radiologe; 2014 Jan; 54(1):69-78; quiz 79-80. PubMed ID: 24326357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy response in malignant pleural mesothelioma-role of MRI using RECIST, modified RECIST and volumetric approaches in comparison with CT.
    Plathow C; Klopp M; Thieke C; Herth F; Thomas A; Schmaehl A; Zuna I; Kauczor HU
    Eur Radiol; 2008 Aug; 18(8):1635-43. PubMed ID: 18369634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecularly targeted therapy using bevacizumab for non-small cell lung cancer: a pilot study for the new CT response criteria.
    Lee HY; Lee KS; Hwang HS; Lee JW; Ahn MJ; Park K; Kim TS; Yi CA; Chung MJ
    Korean J Radiol; 2010; 11(6):618-26. PubMed ID: 21076587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.
    Wahl RL; Jacene H; Kasamon Y; Lodge MA
    J Nucl Med; 2009 May; 50 Suppl 1(Suppl 1):122S-50S. PubMed ID: 19403881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.
    Anzidei M; Napoli A; Zaccagna F; Cartocci G; Saba L; Menichini G; Cavallo Marincola B; Marotta E; Di Mare L; Catalano C; Passariello R
    J Comput Assist Tomogr; 2011; 35(6):690-6. PubMed ID: 22082538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor response and clinical outcome in metastatic gastrointestinal stromal tumors under sunitinib therapy: comparison of RECIST, Choi and volumetric criteria.
    Schramm N; Englhart E; Schlemmer M; Hittinger M; Übleis C; Becker CR; Reiser MF; Berger F
    Eur J Radiol; 2013 Jun; 82(6):951-8. PubMed ID: 23518148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing RECIST with EORTC criteria in metastatic bladder cancer.
    Öztürk H
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):187-94. PubMed ID: 26208817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of Pseudoprogression during Immune Checkpoint Inhibitor Therapy for Solid Tumors: A Systematic Review and Meta-Analysis.
    Park HJ; Kim KW; Pyo J; Suh CH; Yoon S; Hatabu H; Nishino M
    Radiology; 2020 Oct; 297(1):87-96. PubMed ID: 32749204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volumetric Versus Unidimensional Measures of Metastatic Colorectal Cancer in Assessing Disease Response.
    Lubner MG; Stabo N; Lubner SJ; Del Rio AM; Song C; Pickhardt PJ
    Clin Colorectal Cancer; 2017 Dec; 16(4):324-333.e1. PubMed ID: 28433601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cellular mechanisms of tumor response: clinical demands].
    Ganten MK; Weber MA; Ganten TM
    Radiologe; 2008 Sep; 48(9):820-31. PubMed ID: 18754097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor response evaluation in oncology: current update.
    Shanbhogue AK; Karnad AB; Prasad SR
    J Comput Assist Tomogr; 2010 Jul; 34(4):479-84. PubMed ID: 20657213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiological evaluation of the therapeutic response of malignant diseases: status quo, innovative developments and requirements for radiology.
    Höink AJ; Heindel W; Buerke B
    Rofo; 2014 Oct; 186(10):927-36. PubMed ID: 25122173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiologic Pseudoprogression during Anti-PD-1 Therapy for Advanced Non-Small Cell Lung Cancer.
    Katz SI; Hammer M; Bagley SJ; Aggarwal C; Bauml JM; Thompson JC; Nachiappan AC; Simone CB; Langer CJ
    J Thorac Oncol; 2018 Jul; 13(7):978-986. PubMed ID: 29738824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor response assessment: comparison between unstructured free text reporting in routine clinical workflow and computer-aided evaluation based on RECIST 1.1 criteria.
    Goebel J; Hoischen J; Gramsch C; Schemuth HP; Hoffmann AC; Umutlu L; Nassenstein K
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2527-2533. PubMed ID: 28825135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of RECIST 1.1 and iRECIST for Response Evaluation in Solid Tumours].
    Houdek Š; Büchler T; Kindlová E
    Klin Onkol; 2017; 30(Supplementum3):32-39. PubMed ID: 29239190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor growth kinetics versus RECIST to assess response to locoregional therapy in breast cancer liver metastases.
    Seyal AR; Parekh K; Velichko YS; Salem R; Yaghmai V
    Acad Radiol; 2014 Aug; 21(8):950-7. PubMed ID: 24833565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modern magnetic resonance procedures for assessing tumor response].
    Persigehl T; Heindel W; Bremer C
    Radiologe; 2008 Sep; 48(9):863-70. PubMed ID: 18696035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment response classification of liver metastatic disease evaluated on imaging. Are RECIST unidimensional measurements accurate?
    Mantatzis M; Kakolyris S; Amarantidis K; Karayiannakis A; Prassopoulos P
    Eur Radiol; 2009 Jul; 19(7):1809-16. PubMed ID: 19238395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the mRECIST and α-fetoprotein ratio for stratification of the prognosis of advanced-hepatocellular-carcinoma patients treated with sorafenib.
    Kawaoka T; Aikata H; Murakami E; Nakahara T; Naeshiro N; Tanaka M; Honda Y; Miyaki D; Nagaoki Y; Takaki S; Hiramatsu A; Waki K; Takahashi S; Chayama K
    Oncology; 2012; 83(4):192-200. PubMed ID: 22890083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Significance of Discordance between Carcinoembryonic Antigen Levels and RECIST in Metastatic Colorectal Cancer.
    Kim IH; Lee JE; Yang JH; Jeong JW; Ro S; Oh ST; Kim JG; Choi MH; Lee MA
    Cancer Res Treat; 2018 Jan; 50(1):283-292. PubMed ID: 28494536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.